Hear This Idea #78 – Jacob Trefethen on Global Health R&D
17 snips
Sep 8, 2024 
Jacob Trefethen, overseeing science policy programs at Open Philanthropy, explores the urgent need for innovative health technologies, like a TB vaccine. He discusses the complexities of R&D for neglected diseases, emphasizing funding disparities and the slow drug development process. Trefethen offers no-brainer policy ideas to speed up global health advancements and questions the future role of AI in research. The conversation also highlights the challenges in diagnostics and the vital need for effective partnerships in healthcare improvements.
AI Snips
Chapters
Transcript
Episode notes
Clinical Trial Challenges for Rare Diseases
- Clinical trials for diseases with rarer but severe infections require larger sample sizes.
- This is due to the need for statistically significant results and the lower incidence of the disease.
Strep A and Vaccine Gap
- Strep A is a common bacteria, causing strep throat and potentially rheumatic heart disease.
- Despite its impact, there's no vaccine, partly due to past FDA restrictions on testing.
Monoclonal Antibodies for Malaria
- Monoclonal antibodies offer a potential alternative to traditional vaccines and drugs.
- They could be particularly useful for malaria prevention but are currently expensive.